Appropriateness of the institute certification system for esophageal surgeries by the Japan Esophageal Society: evaluation of survival outcomes using data from the National Database of Hospital-Based Cancer Registries in Japan.
Aged
Cancer Care Facilities
/ standards
Certification
Chemotherapy, Adjuvant
Clinical Competence
Databases, Factual
Esophageal Neoplasms
/ pathology
Esophagectomy
/ methods
Female
Humans
Japan
Kaplan-Meier Estimate
Male
Middle Aged
Neoplasm Staging
Radiotherapy, Adjuvant
Registries
Societies, Medical
Treatment Outcome
Esophageal cancer
Esophagectomy
Institute certification
Survival outcome
Journal
Esophagus : official journal of the Japan Esophageal Society
ISSN: 1612-9067
Titre abrégé: Esophagus
Pays: Japan
ID NLM: 101206627
Informations de publication
Date de publication:
01 2019
01 2019
Historique:
received:
29
06
2018
accepted:
08
10
2018
pubmed:
17
10
2018
medline:
29
5
2019
entrez:
17
10
2018
Statut:
ppublish
Résumé
Since 2013, The Japan Esophageal Society has been certifying "Authorized Institute for Board Certified Esophageal Surgeon (AIBCES)" to contribute to improving national medical care by enhancing the professional knowledge and skills of esophageal surgeons. However, the appropriateness on this certification system has not yet been verified. Our aim was to assess the appropriateness of the institute certification system for esophageal surgeries used by the medical society. Using data from the National Database of Hospital-based Cancer Registries, we analyzed the 5-year overall survival rates among 2135 patients with thoracic esophageal cancer who underwent an esophagectomy at 53 AIBCES or 141 non-AIBCES. There were 1343 (63%) patients who underwent surgery at an AIBCES and 792 (37%) who underwent surgery at a non-AIBCES. Registered patients were followed up for a median of 53 (range 1-88) months. Over the followed-up period examined, 670 (50%) patients treated at an AIBCES died and 455 (57%) treated at a non-AIBCES died. Comparison of the Kaplan-Meier survival curves indicated that patients with cStage II or cStage III disease treated at an AIBCES had significantly better 5-year survival rates than those treated at a non-AIBCES (55.4% vs. 44.9% and 38.0% vs. 30.3%, respectively). Univariate and multivariate analyses stratified based on stages and adjuvant therapies revealed that institute certification (AIBCES vs. non-AIBCES) is a significant independent factor for 5-year survival. The institute certification system used by the Japan Esophageal Society may be appropriate, as indicated by improved 5-year survival outcomes. The institute certification system has the potential to contribute to a more appropriate medical delivery system in the future.
Sections du résumé
BACKGROUND
Since 2013, The Japan Esophageal Society has been certifying "Authorized Institute for Board Certified Esophageal Surgeon (AIBCES)" to contribute to improving national medical care by enhancing the professional knowledge and skills of esophageal surgeons. However, the appropriateness on this certification system has not yet been verified. Our aim was to assess the appropriateness of the institute certification system for esophageal surgeries used by the medical society.
METHODS
Using data from the National Database of Hospital-based Cancer Registries, we analyzed the 5-year overall survival rates among 2135 patients with thoracic esophageal cancer who underwent an esophagectomy at 53 AIBCES or 141 non-AIBCES.
RESULTS
There were 1343 (63%) patients who underwent surgery at an AIBCES and 792 (37%) who underwent surgery at a non-AIBCES. Registered patients were followed up for a median of 53 (range 1-88) months. Over the followed-up period examined, 670 (50%) patients treated at an AIBCES died and 455 (57%) treated at a non-AIBCES died. Comparison of the Kaplan-Meier survival curves indicated that patients with cStage II or cStage III disease treated at an AIBCES had significantly better 5-year survival rates than those treated at a non-AIBCES (55.4% vs. 44.9% and 38.0% vs. 30.3%, respectively). Univariate and multivariate analyses stratified based on stages and adjuvant therapies revealed that institute certification (AIBCES vs. non-AIBCES) is a significant independent factor for 5-year survival.
CONCLUSIONS
The institute certification system used by the Japan Esophageal Society may be appropriate, as indicated by improved 5-year survival outcomes. The institute certification system has the potential to contribute to a more appropriate medical delivery system in the future.
Identifiants
pubmed: 30324431
doi: 10.1007/s10388-018-0646-4
pii: 10.1007/s10388-018-0646-4
pmc: PMC6514086
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
114-121Références
Tachimori Y, Ozawa S, Numasaki H, et al. Registration Committee for Esophageal Cancer of the Japan Esophageal Society. Comprehensive Registry of Esophageal Cancer in Japan, 2010. Esophagus. 2017;14:189–214.
doi: 10.1007/s10388-017-0578-4
pubmed: 28725168
pmcid: 5486463
Chen MF, Yang YH, Lai CH, et al. Outcome of patients with esophageal cancer: a nationwide analysis. Ann Surg Oncol. 2013;20:3023–30.
doi: 10.1245/s10434-013-2935-4
pubmed: 23525703
Tachimori Y, Ozawa S, Numasaki H, et al. Efficacy of lymph node dissection by node zones according to tumor location for esophageal squamous cell carcinoma. Esophagus. 2016;13:1–7.
doi: 10.1007/s10388-015-0515-3
Ando N, Kato H, Igaki H, et al. A randomized trial comparing postoperative adjuvant chemotherapy with cisplatin and 5-fluorouracil versus preoperative chemotherapy for localized advanced squamous cell carcinoma of the thoracic esophagus (JCOG9907). Ann Surg Oncol. 2012;19:68–74.
doi: 10.1245/s10434-011-2049-9
van Hagen P, Hulshof MC, van Lanschot JJ, et al. Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med. 2012;366:2074–84.
doi: 10.1056/NEJMoa1112088
Higashi T, Nakamura F, Shibata A, et al. The national database of hospital-based cancer registries: a nationwide infrastructure to support evidence-based cancer care and cancer control policy in Japan. Jpn J Clin Oncol. 2014;44:2–8.
doi: 10.1093/jjco/hyt013
pubmed: 23448800
Takeuchi H, Miyata H, Gotoh M, et al. A risk model for esophagectomy using data of 5354 patients included in a Japanese nationwide web-based database. Ann Surg. 2014;260:259–66.
doi: 10.1097/SLA.0000000000000644
Kunisaki C, Miyata H, Konno H, et al. Modeling preoperative risk factors for potentially lethal morbidities using a nationwide Japanese web-based database of patients undergoing distal gastrectomy for gastric cancer. Gastric Cancer. 2017;20:496–507.
doi: 10.1007/s10120-016-0634-0
pubmed: 27553666
Takahara T, Wakabayashi G, Konno H, et al. Comparison of laparoscopic major hepatectomy with propensity score matched open cases from the National Clinical Database in Japan. J Hepatobiliary Pancreat Sci. 2016;23:721–34.
doi: 10.1002/jhbp.405
pubmed: 27685870
Crossing the Quality Chasm: A New Health System for the 21st Century. Institute of Medicine (US) Committee on Quality of Health Care in America. Washington (DC): National Academies Press (US); 2001.
Wouters MW, Gooiker GA, van Sandick JW, et al. The volume–outcome relation in the surgical treatment of esophageal cancer: a systematic review and meta-analysis. Cancer. 2012;118:1754–63.
doi: 10.1002/cncr.26383
pubmed: 22009562
Nishigori T, Miyata H, Okabe H, et al. Impact of hospital volume on risk-adjusted mortality following oesophagectomy in Japan. Br J Surg. 2016;103:1880–6.
doi: 10.1002/bjs.10307
pubmed: 27683023
Fuchs HF, Harnsberger CR, Broderick RC, et al. Mortality after esophagectomy is heavily impacted by center volume: retrospective analysis of the Nationwide Inpatient Sample. Surg Endosc. 2017;31:2491–7.
doi: 10.1007/s00464-016-5251-9
pubmed: 27660245
Markar SR, Mackenzie H, Askari A, et al. Effect of esophageal cancer surgeon volume on management and mortality from emergency upper gastrointestinal conditions: population-based cohort study. Ann Surg. 2017;266:847–53.
doi: 10.1097/SLA.0000000000002387
Chang AC. Centralizing esophagectomy to improve outcomes and enhance clinical research: invited expert review. Ann Thorac Surg. 2018;106:916–23.
doi: 10.1016/j.athoracsur.2018.04.004
pubmed: 29738757
Munasinghe A, Markar SR, Mamidanna R, et al. Is it time to centralize high-risk cancer care in the United States? Comparison of outcomes of esophagectomy between England and the United States. Ann Surg. 2015;262:79–85.
doi: 10.1097/SLA.0000000000000805
pubmed: 24979602
Fujita H, Ozawa S, Kuwano H, et al. Committee for Scientific Affairs, Japanese Association for Thoracic Surgery. Esophagectomy for cancer: clinical concerns support centralizing operations within the larger hospitals. Dis Esophagus. 2010;23:145–52.
doi: 10.1111/j.1442-2050.2009.00986.x
pubmed: 19515188
Ghaferi AA, Birkmeyer JD, Dimick JB. Hospital volume and failure to rescue with high-risk surgery. Med Care. 2011;49:1076–81.
doi: 10.1097/MLR.0b013e3182329b97
pubmed: 22002649
Silber JH, Rosenbaum PR, McHugh MD, et al. Comparison of the value of nursing work environments in hospitals across different levels of patient risk. JAMA surgery. 2016;151:527–36.
doi: 10.1001/jamasurg.2015.4908
pubmed: 26791112
pmcid: 4957817
Donabedian A. Evaluating the quality of medical care. Milbank Mem Fund Q. 1966;44:166–206.
doi: 10.2307/3348969
Tsukada Y, Higashi T, Shimada H, et al. The use of neoadjuvant therapy for resectable locally advanced thoracic esophageal squamous cell carcinoma in an analysis of 5016 patients from 305 designated cancer care hospitals in Japan. Int J Clin Oncol. 2018;23:81–91.
doi: 10.1007/s10147-017-1178-y
pubmed: 28795280